These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 7910536)
1. Dipeptidyl peptidase IV (DP IV) activity in serum and on lymphocytes of MRL/Mp-lpr/lpr mice correlates with disease onset. Kubota T; Iizuka H; Bachovchin WW; Stollar BD Clin Exp Immunol; 1994 May; 96(2):292-6. PubMed ID: 7910536 [TBL] [Abstract][Full Text] [Related]
2. Involvement of dipeptidyl peptidase IV in an in vivo immune response. Kubota T; Flentke GR; Bachovchin WW; Stollar BD Clin Exp Immunol; 1992 Aug; 89(2):192-7. PubMed ID: 1353423 [TBL] [Abstract][Full Text] [Related]
3. Role of dipeptidyl peptidase IV (DP IV)-like enzymes in T lymphocyte activation: investigations in DP IV/CD26-knockout mice. Reinhold D; Goihl A; Wrenger S; Reinhold A; Kühlmann UC; Faust J; Neubert K; Thielitz A; Brocke S; Täger M; Ansorge S; Bank U Clin Chem Lab Med; 2009; 47(3):268-74. PubMed ID: 19676138 [TBL] [Abstract][Full Text] [Related]
4. Suppressor T-cell activity in MRL/Mp-lpr/lpr mice: differential effects on primary and memory antibody responses of MRL/Mp-lpr/lpr and MRL/Mp-+/+ spleen cells to thymus dependent and thymus independent antigens in vitro. Wilson DA Cell Immunol; 1985 Dec; 96(2):312-26. PubMed ID: 2943418 [TBL] [Abstract][Full Text] [Related]
5. Activities of dipeptidyl peptidases in BXSB mice and MRL/lpr mice with lupus erythematosus-like syndrome. Hagihara M; Fujiwara M; Nagatsu T Biochem Med Metab Biol; 1989 Dec; 42(3):224-31. PubMed ID: 2574590 [TBL] [Abstract][Full Text] [Related]
6. [Functional studies of adhesion molecules on CD4-CD8- double negative T cells of autoimmune MRL/Mp-lpr/mice]. Wang W Hokkaido Igaku Zasshi; 1993 Sep; 68(5):755-66. PubMed ID: 8225181 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of dipeptidyl aminopeptidase IV (DP-IV) by Xaa-boroPro dipeptides and use of these inhibitors to examine the role of DP-IV in T-cell function. Flentke GR; Munoz E; Huber BT; Plaut AG; Kettner CA; Bachovchin WW Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1556-9. PubMed ID: 1671716 [TBL] [Abstract][Full Text] [Related]
8. The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/MP-lpr/lpr mice. Huang FP; Feng GJ; Lindop G; Stott DI; Liew FY J Exp Med; 1996 Apr; 183(4):1447-59. PubMed ID: 8666903 [TBL] [Abstract][Full Text] [Related]
9. Unique surface phenotype of T cells in lymphoproliferative autoimmune MRL/Mp-lpr/lpr mice. Takei F J Immunol; 1984 Oct; 133(4):1951-4. PubMed ID: 6332141 [TBL] [Abstract][Full Text] [Related]
10. Autoreactivity accelerates the development of autoimmunity and lymphoproliferation in MRL/Mp-lpr/lpr mice. Weston KM; Yeh ET; Sy MS J Immunol; 1987 Aug; 139(3):734-42. PubMed ID: 3110283 [TBL] [Abstract][Full Text] [Related]
11. Dipeptidyl peptidase IV in human T-lymphocytes: cytochemical and histochemical investigations in patients with non-Hodgkin's lymphoma. Schön E; Essbach U; Machura R; Franke A; Ansorge S Acta Histochem Suppl; 1986; 33():131-8. PubMed ID: 2874587 [TBL] [Abstract][Full Text] [Related]
12. Quantitative studies on T-cell functions in MRL/MP-Lpr/Lpr mice. I. Frequency analysis of precursor cells of proliferating, cytotoxic, and T-cell growth factor-secreting T lymphocytes reveals an increase in absolute numbers, with a concomitant decrease in percentage of immunocompetent cells. Simon MM; Prester M; Nerz G; Kuppers RC Clin Immunol Immunopathol; 1984 Oct; 33(1):39-53. PubMed ID: 6332698 [TBL] [Abstract][Full Text] [Related]
13. Separation of L-Pro-DL-boroPro into its component diastereomers and kinetic analysis of their inhibition of dipeptidyl peptidase IV. A new method for the analysis of slow, tight-binding inhibition. Gutheil WG; Bachovchin WW Biochemistry; 1993 Aug; 32(34):8723-31. PubMed ID: 8103356 [TBL] [Abstract][Full Text] [Related]
14. Effects of deoxyspergualin on dipeptidyl peptidase-II and -IV in the spleen of BXSB mice and MRL/lpr mice during the development of the lupus erythematosus-like syndrome. Hagihara M; Sekiguchi K; Fujiwara M; Aoyagi T; Takeuchi T; Nagatsu T Biochem Pharmacol; 1992 Mar; 43(6):1380-3. PubMed ID: 1348619 [No Abstract] [Full Text] [Related]
15. Vaccination with autoreactive CD4(+)Th1 clones in lupus-prone MRL/Mp-Fas(lpr/lpr) mice. Fujii T; Okada M; Fujita Y; Sato T; Tanaka M; Usui T; Umehara H; Mimori T J Autoimmun; 2009 Sep; 33(2):125-34. PubMed ID: 19596182 [TBL] [Abstract][Full Text] [Related]
16. The effect of a selective estrogen receptor modulator on the progression of spontaneous autoimmune disease in MRL lpr/lpr mice. Apelgren LD; Bailey DL; Fouts RL; Short L; Bryan N; Evans GF; Sandusky GE; Zuckerman SH; Glasebrook A; Bumol TF Cell Immunol; 1996 Oct; 173(1):55-63. PubMed ID: 8871601 [TBL] [Abstract][Full Text] [Related]
17. Lymph node cell vaccination against the lupus syndrome of MRL/lpr/lpr mice. Ben-Yehuda A; Bar-Tana R; Livoff A; Ron N; Cohen IR; Naparstek Y Lupus; 1996 Jun; 5(3):232-6. PubMed ID: 8803896 [TBL] [Abstract][Full Text] [Related]
18. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus. Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011 [TBL] [Abstract][Full Text] [Related]
19. Autoreactive T cells in MRL/Mpr-lpr/lpr mice. Characterization of the lymphokines produced and analysis of antigen-presenting cells required. Weston KM; Ju ST; Lu CY; Sy MS J Immunol; 1988 Sep; 141(6):1941-8. PubMed ID: 3139746 [TBL] [Abstract][Full Text] [Related]
20. Identification of a B cell differentiation factor(s) spontaneously produced by proliferating T cells in murine lupus strains of the lpr/lpr genotype. Prud'Homme GJ; Park CL; Fieser TM; Kofler R; Dixon FJ; Theofilopoulos AN J Exp Med; 1983 Feb; 157(2):730-42. PubMed ID: 6600490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]